Speculators say Bayer’s potential bid for Monsanto may lead to the company selling some assets to help fund its quest for the seed company worth an estimated $43 billion. Bayer has held preliminary discussions internally and with advisers on an offer for Monsanto, according to Bloomberg, which reports deliberations remain private. Market experts say Bayer could shed its stake in its plastics unit and its animal-health business to make the acquisition work. BASF is also reportedly considering a bid for Monsanto. The potential bids are just the latest in a line of acquisitions within the industry. Dow Chemical and DuPont agreed to a merger in December of last year, and ChemChina agreed to Purchase Syngenta earlier this year. Both deals face U.S. regulatory scrutiny.